A single, low, oral dose of a 5-carbon-linked trioxane dimer orthoester plus mefloquine cures malaria-infected mice
Authors:
- 1 May 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (9) , 2773-2775
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Antimalarial preclinical drug development: a single oral dose of a 5‐carbon‐linked trioxane dimer plus mefloquine cures malaria‐infected miceDrug Development Research, 2009
- Malaria-Infected Mice Live until at Least Day 30 after a New Monomeric Trioxane Combined with Mefloquine Are Administered Together in a Single Low Oral DoseJournal of Medicinal Chemistry, 2009
- Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trialMalaria Journal, 2009
- The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparumMalaria Journal, 2009
- Malaria-Infected Mice Are Cured by a Single Oral Dose of New Dimeric Trioxane Sulfones Which Are Also Selectively and Powerfully Cytotoxic to Cancer CellsJournal of Medicinal Chemistry, 2009
- Synthesis, Antimalarial Activity, and Intracellular Targets of MEFAS, a New Hybrid Compound Derived from Mefloquine and ArtesunateAntimicrobial Agents and Chemotherapy, 2008
- Drug discovery for malaria: a very challenging and timely endeavorCurrent Opinion in Chemical Biology, 2007
- Synthetic peroxides as antimalarialsMedicinal Research Reviews, 2004
- Reaction of 1,2-dioxetanes with heteroatom nucleophiles: adduct formation by nucleophilic attack at the peroxide bondJournal of the American Chemical Society, 1992
- Qinghaosu (Artemisinin): an Antimalarial Drug from ChinaScience, 1985